TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells

被引:31
|
作者
Ding, Yan [1 ,2 ]
Yu, Ai Qing [1 ]
Li, Cheng Lin [1 ]
Fang, Juan [1 ]
Zeng, Yi [2 ]
Li, Dong Sheng [1 ]
机构
[1] Hubei Univ Med, Taihe Hosp, Hubei Key Lab Embryon Stem Cell Res, Shiyan, Hubei, Peoples R China
[2] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China
关键词
Nanog; Hela cell; cervical cancer cell; TALEN; epithelial-mesenchymal transition; MULTIDRUG-RESISTANCE; STEM; PLURIPOTENCY; CADHERIN;
D O I
10.18632/oncotarget.2298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence suggests that Nanog is involved in cervical tumorigenesis. However, the regulating role of Nanog in tumorigenesis and chemosensitivity are still poorly understood. In this study, Nanog was disrupted by transcription activator-like effector nucleases (TALEN) in Hela cells and its expression was significantly decreased in a single-cell derived sub-clone with biallelic mutations. The disruption of Nanog not only induced down regulation of some other core transcription factor genes for cell self-renewal, such as Oct4, Sox2 and FoxD3, but also led to the down regulation of some mesenchymal representative genes, vimentin and N-adherin, and up regulation of the epithelial gene, E-cadherin. In addition, the invasiveness and clonogenicity of the Hela cells were obviously affected, and surprisingly their sensitivities to anti-cancer drugs were also significantly increased in vitro. After Xenograft into nude mice, the growth volumes of the neoplasms from the Nanog disrupted Hela cells were significantly smaller compared with those from wild type ones. In conclusion, these results suggest that disruption of Nanog may reverse the status of epithelial-mesenchymal transition, which is critical in tumorigenesis, and alleviate chemoresistance, as well as their invasiveness, in cervical cancer cells.
引用
收藏
页码:8393 / 8401
页数:9
相关论文
共 5 条
  • [1] TALEN-induced disruption of Nanog expression results in reduced proliferation, invasiveness and migration, increased chemosensitivity and reversal of EMT in HepG2 cells
    Yu, Ai Qing
    Ding, Yan
    Li, Cheng Lin
    Yang, Yi
    Yan, Shi Rong
    Li, Dong Sheng
    ONCOLOGY REPORTS, 2016, 35 (03) : 1657 - 1663
  • [2] TALEN-Mediated Gene Editing of LPA Results in Gene Disruption and Plasma Lipoprotein(a) Reduction in Transgenic Mice
    Garcia, Daniel A.
    MOLECULAR THERAPY, 2023, 31 (04) : 793 - 793
  • [3] Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N-Trp53tm1Hw1 with TALEN-mediated Trp53 mutant gene
    Woobin Yun
    Ji Eun Kim
    You Jeong Jin
    Yu Jeong Roh
    Hee Jin Song
    Ayun Seol
    Tae Ryeol Kim
    Kyeong Seon Min
    Eun Seo Park
    Gi Ho Park
    Hyun Gu Kang
    Yeon Shik Choi
    Dae Youn Hwang
    Laboratory Animal Research, 39
  • [4] Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N-Trp53tm1Hw1 with TALEN-mediated Trp53 mutant gene
    Yun, Woobin
    Kim, Ji Eun
    Jin, You Jeong
    Roh, Yu Jeong
    Song, Hee Jin
    Seol, Ayun
    Kim, Tae Ryeol
    Min, Kyeong Seon
    Park, Eun Seo
    Park, Gi Ho
    Kang, Hyun Gu
    Choi, Yeon Shik
    Hwang, Dae Youn
    LABORATORY ANIMAL RESEARCH, 2023, 39 (01)
  • [5] Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells
    Patsali, Petros
    Turchiano, Giandomenico
    Papasavva, Panayiota
    Romito, Marianna
    Loucari, Constantinos C.
    Stephanou, Coralea
    Christou, Soteroulla
    Sitarou, Maria
    Mussolino, Claudio
    Cornu, Tatjana I.
    Antoniou, Michael N.
    Lederer, Carsten W.
    Cathomen, Toni
    Kleanthous, Marina
    HAEMATOLOGICA, 2019, 104 (11) : E497 - E501